Owkin Company
Owkin is an AI precision medicine company with a vision to find the right drug for every patient.
Investors
Funding Status:
Early Stage Venture
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Technology:
Artificial Intelligence, Biotechnology, Clinical Trials, Machine Learning, Software
Headquarters:
New York, New York, United States
Total Funding:
304100000.0
Last Funding Date:
2022-06-08
Last Funding Type:
Series B
Investor Type:
contact@owkin.com
Employee Number:
51-100
Investors Number:
16.0
Founded Date:
2016-01-01